Literature DB >> 17325330

Necessary cautions when considering digoxin in heart failure.

George A Heckman1, Robert S McKelvie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17325330      PMCID： PMC1800339          DOI： 10.1503/cmaj.061309

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Trials stopped early: too good to be true?

Authors:  S Pocock; I White
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study.

Authors:  M W Rich; F McSherry; W O Williford; S Yusuf
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

3.  The effect of digoxin on mortality and morbidity in patients with heart failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-20       Impact factor: 91.245

4.  Sex-based differences in the effect of digoxin for the treatment of heart failure.

Authors:  Saif S Rathore; Yongfei Wang; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

5.  Effect of aging on the incidence of digoxin toxicity.

Authors:  T Miura; R Kojima; Y Sugiura; M Mizutani; F Takatsu; Y Suzuki
Journal:  Ann Pharmacother       Date:  2000-04       Impact factor: 3.154

6.  Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

Authors:  Ali Ahmed; Michael W Rich; Thomas E Love; Donald M Lloyd-Jones; Inmaculada B Aban; Wilson S Colucci; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2005-12-08       Impact factor: 29.983

Review 7.  Differential pharmacokinetics of digoxin in elderly patients.

Authors:  C G Hanratty; P McGlinchey; G D Johnston; A P Passmore
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

8.  Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.

Authors:  Kirkwood F Adams; J Herbert Patterson; Wendy A Gattis; Christopher M O'Connor; Craig R Lee; Todd A Schwartz; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

9.  Association of serum digoxin concentration and outcomes in patients with heart failure.

Authors:  Saif S Rathore; Jeptha P Curtis; Yongfei Wang; Michael R Bristow; Harlan M Krumholz
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

10.  Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Authors:  Ali Ahmed; Michael W Rich; Jerome L Fleg; Michael R Zile; James B Young; Dalane W Kitzman; Thomas E Love; Wilbert S Aronow; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690
View more
  2 in total

1.  Appropriateness of serum digoxin levels.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Giorgio Brocco; Gian Cesare Guidi
Journal:  Eur J Clin Pharmacol       Date:  2007-09-16       Impact factor: 2.953

2.  Is a subgroup claim believable? A user's guide to subgroup analyses in the surgical literature.

Authors:  Xin Sun; Diane Heels-Ansdell; Stephen D Walter; Gordon Guyatt; Sheila Sprague; Mohit Bhandari; David Sanders; Emil Schemitsch; Paul Tornetta; Marc Swiontkowski
Journal:  J Bone Joint Surg Am       Date:  2011-02-02       Impact factor: 5.284
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.